Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

Charles Lister, providing advice to Lord Hunt regarding the Hepatitis C litigation against the National Blood Authority, noted that settlement of that litigation (or an award of damages by the court) would give rise to "inevitable claims of inequity from the Haemophilia Society".

Published on: 15 August, 2024

Lord Hunt noted a clear and defendable distinction between settlement of litigation and the Government's continued refusal to compensate people with haemophilia infected with HCV through blood products on the basis of non-negligent harm.

Published on: 15 August, 2024

In October 2000, Lord Hunt sought advice on what could be offered in terms of a package of care for victims of HCV, as noted in an email chain from Sue Cartwright to Charles Lister.

Published on: 15 August, 2024

In a memo from Jane Verity and Charles Lister to Sue Cartwright, officials provided Lord Hunt a co-ordinated approach to problems associated with Hepatitis C treatment.

Published on: 15 August, 2024

In a memo from Lord Hunt to others, he proposed a co-ordinated package of care to those infected with HCV.

Published on: 15 August, 2024

Charles Lister in his statement to the Inquiry stated that Sandra Falconer noted that the Scottish Executive was seeking to maintain the common UK position.

Published on: 15 August, 2024

Charles Lister in his statement noted that campaigners from Manor House and Haemophilia Action UK staged a protest march demanding compensation.

Published on: 15 August, 2024

Charles Lister responded to questions by Yvette Cooper noting that it would be difficult to make payments to those with haemophilia without making payments to those infected via blood transfusion.

Published on: 15 August, 2024

In early July 2001, Yvette Cooper approved an amended line to take regarding ministers "reviewing the case for compensation".

Published on: 15 August, 2024

At a meeting of SNBTS and hemophilia directors Professor Ludlam explained 16 haemophilia patients treated with SNBTS Factor 8 had been infected with HTLV 3.

Published on: 30 September, 2024

At a meeting of SNBTS and heamophilia directors Dr Forbes spoke of findings relating to HTLV 3 antibody seroconversion in a comparative study of haemophilia patients in Glasgow and Denmark.

Published on: 30 September, 2024

At a meeting of SNBTS and haemophilia directors Dr Brenda Gibson reported five out of ten patients tested at the Royal Hospital for Sick Children (Yorkhill) were HIV positive.

Published on: 30 September, 2024

At a meeting of SNBTS and haemophilia directors it was agreed that patients should be informed about the recent findings in relation to patients with haemophilia being infected with HIV before additional publicity was given.

Published on: 30 September, 2024

In 1983 there was an increase in the use of commercial concentrates (200,000 units of Factorate for home treatment), although NHS concentrates remained the mainstay of treatment at the Glasgow Haemophilia Centre.

Published on: 30 September, 2024

In 1984, the use of commercial concentrates dropped again at the Glasgow Haemophilia Centre.

Published on: 30 September, 2024

Professor Gordon Lowe confirmed in his oral evidence that he became aware of AIDS cases in haemophiliacs in late 1982 from Professor Forbes who was initiating a study of immune abnormalities in patients with severe haemophilia. The conclusion of the study was that Scottish patients had immunological abnormalities similar to those in their US counterparts.

Published on: 30 September, 2024

Professor Goron Lowe stated in his oral evidence that Dr Forbes confirmed in his Penrose Inquiry evidence that blood was taken from 77 Scottish people between December 1983 and July 1984, and they were not told that their blood was being tested for HIV. None of the 12 patients who had tested positive had been told of their HIV test results.

Published on: 30 September, 2024

A study of immune abnormalities in patients with severe haemophilia resulted in the publication in of a paper entitled "Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate"? The study concluded that Scottish patients had immunological abnormalities similar to those in their US counterparts.

Published on: 30 September, 2024

It was recorded that 5 young homosexual men had contracted opportunistic infections such as pneumocystis, pneumonia, cryptococcosis or severe candidiasis.

Published on: 30 September, 2024

Dr Mayne wrote to the Lancet that the evolving HIV problem within the haemophilia population had "caused immeasurable distress to patients and to all physicians treating them. The Doctors concerned were guilty of one fault, namely that of ignorance."

Published on: 30 September, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2316
  • Page 2317
  • Page 2318
  • Page 2319
  • Current page 2320
  • Page 2321
  • Page 2322
  • Page 2323
  • Page 2324
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.